Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.48 |
| ▸ | GGT1 | P19440 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | S1PR2 | O95136 | 2/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.45 |
| ▸ | CTSK | P43235 | 1/20 | 0.43 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.42 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.42 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | TLR2 | O60603 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7382823 | 0.95 | NOD1 (0.52) | NOD1GGT1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL7383218 | 0.92 | GGT1 (0.53) | GGT1GRIK1HDAC3LTA4HMME | |
| Homophenylalanine SCHEMBL7383933 | 0.90 | GGT1 (0.50) | GGT1GRIK1HDAC3LTA4HMME | |
| Ornithine SCHEMBL7376158 | 0.89 | GGT1 (0.48) | GGT1GRIK1CHRNB2CHRNB4CHRNA3 | |
| Glutamic Acid SCHEMBL7375280 | 0.89 | GGT1 (0.49) | GGT1CYP1A2GRIK1LTA4HMME | |
| Lysine SCHEMBL7384968 | 0.88 | GGT1 (0.47) | GGT1GRIK1CHRNB2CHRNB4CHRNA3 | |
| Serine SCHEMBL7384366 | 0.85 | GGT1 (0.48) | GGT1GRIK1HDAC3LTA4HMME | |
| Phenylalanine SCHEMBL7432097 | 0.85 | ALPI (0.56) | GGT1LTA4HMME | |
| Alanine SCHEMBL7382718 | 0.85 | GGT1 (0.50) | GGT1CYP2C9CYP2C19HPGDMME | |
| SCHEMBL6423726 | 0.85 | GGT1 (0.57) | GGT1HDAC3MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1098662-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2001-05-16 | — | — | EP | disclosed |
| EP-1063991-A1 | STATIN-MATRIX METALLOPROTEINASE INHIBITOR COMBINATIONS | WARNER-LAMBERT COMPANY LLC (US) | 2001-01-03 | — | — | EP | disclosed |
| WO-2000004892-A2 | COADMINISTRATION OF ACAT AND MMP INHIBITORS FOR THE TREATMENT OF ATHEROSCLEROTIC LESIONS | WARNER-LAMBERT COMPANY (US) | 2000-02-03 | — | — | WO | disclosed |
| WO-1999047138-A1 | STATIN-MATRIX METALLOPROTEINASE INHIBITOR COMBINATIONS | WARNER-LAMBERT COMPANY (US) | 1999-09-23 | — | — | WO | disclosed |